Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial.

Lyubarova R, Albers JJ, Marcovina SM, Yao Y, McBride R, Topliceanu A, Anderson T, Fleg JL, Desvigne-Nickens P, Kashyap ML, McGovern ME, Boden WE.

J Cardiovasc Pharmacol Ther. 2019 Nov;24(6):534-541. doi: 10.1177/1074248419852955. Epub 2019 May 26.

PMID:
31131629
2.

Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection.

Albers JJ, Ammon T, Gosmann D, Audehm S, Thoene S, Winter C, Secci R, Wolf A, Stelzl A, Steiger K, Ruland J, Bassermann F, Kupatt C, Anton M, Krackhardt AM.

Life Sci Alliance. 2019 Mar 15;2(2). pii: e201900367. doi: 10.26508/lsa.201900367. Print 2019 Apr.

3.

Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP).

Zhang M, Zhai X, Li J, Albers JJ, Vuletic S, Ren G.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1082-1094. doi: 10.1016/j.bbalip.2018.06.001. Epub 2018 Jun 5.

4.

Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study.

Zhao XQ, Phan BA, Davis J, Isquith D, Dowdy AA, Boltz S, Neradilek M, Monick EA, Brockenbrough A, Hus-Frechette EE, Albers JJ, Brown BG.

J Clin Lipidol. 2016 Sep-Oct;10(5):1091-7. doi: 10.1016/j.jacl.2016.06.013. Epub 2016 Jul 9.

5.

Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.

Albers JJ, Slee A, Fleg JL, O'Brien KD, Marcovina SM.

Atherosclerosis. 2016 Aug;251:454-459. doi: 10.1016/j.atherosclerosis.2016.06.019. Epub 2016 Jun 11.

6.

Lipoprotein (a) measurements for clinical application.

Marcovina SM, Albers JJ.

J Lipid Res. 2016 Apr;57(4):526-37. doi: 10.1194/jlr.R061648. Epub 2015 Dec 4. Review.

7.

Inhibition of thrombin generation in human plasma by phospholipid transfer protein.

Deguchi H, Wolfbauer G, Cheung MC, Banerjee Y, Elias DJ, Fernández JA, Albers JJ, Griffin JH.

Thromb J. 2015 Jul 16;13:24. doi: 10.1186/s12959-015-0054-0. eCollection 2015.

8.

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Kim DS, Burt AA, Ranchalis JE, Vuletic S, Vaisar T, Li WF, Rosenthal EA, Dong W, Eintracht JF, Motulsky AG, Brunzell JD, Albers JJ, Furlong CE, Jarvik GP.

J Lipid Res. 2015 Jul;56(7):1351-62. doi: 10.1194/jlr.P058032. Epub 2015 May 25.

9.

HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants.

Kim DS, Burt AA, Rosenthal EA, Ranchalis JE, Eintracht JF, Hatsukami TS, Furlong CE, Marcovina S, Albers JJ, Jarvik GP.

J Am Heart Assoc. 2014 Jun 25;3(3):e000902. doi: 10.1161/JAHA.114.000902.

10.

Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.

Vuletic S, Kennedy H, Albers JJ, Killestein J, Vrenken H, Lütjohann D, Teunissen CE.

Mult Scler Relat Disord. 2014 Jul 1;3(4):533-541.

11.

Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains.

Gong H, Dong W, Rostad SW, Marcovina SM, Albers JJ, Brunzell JD, Vuletic S.

J Histochem Cytochem. 2013 Dec;61(12):857-68. doi: 10.1369/0022155413505601. Epub 2013 Sep 4.

12.

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO Jr, Xu P, Marcovina SM.

J Am Coll Cardiol. 2013 Oct 22;62(17):1575-9. doi: 10.1016/j.jacc.2013.06.051. Epub 2013 Aug 21.

13.

PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages.

Vuletic S, Dong W, Wolfbauer G, Tang C, Albers JJ.

Biochim Biophys Acta. 2011 Oct;1813(10):1917-24. doi: 10.1016/j.bbamcr.2011.06.013. Epub 2011 Jul 3.

14.

Linkage and association of phospholipid transfer protein activity to LASS4.

Rosenthal EA, Ronald J, Rothstein J, Rajagopalan R, Ranchalis J, Wolfbauer G, Albers JJ, Brunzell JD, Motulsky AG, Rieder MJ, Nickerson DA, Wijsman EM, Jarvik GP.

J Lipid Res. 2011 Oct;52(10):1837-46. doi: 10.1194/jlr.P016576. Epub 2011 Jul 13.

15.

Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Albers JJ, Vuletic S, Cheung MC.

Biochim Biophys Acta. 2012 Mar;1821(3):345-57. doi: 10.1016/j.bbalip.2011.06.013. Epub 2011 Jun 28. Review.

16.

Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein.

Albers JJ, Day JR, Wolfbauer G, Kennedy H, Vuletic S, Cheung MC.

Biochim Biophys Acta. 2011 Jul;1814(7):908-11. doi: 10.1016/j.bbapap.2011.04.004. Epub 2011 Apr 16.

17.

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.

Lamon-Fava S, Marcovina SM, Albers JJ, Kennedy H, Deluca C, White CC, Cupples LA, McNamara JR, Seman LJ, Bongard V, Schaefer EJ.

J Lipid Res. 2011 Jun;52(6):1181-7. doi: 10.1194/jlr.M012526. Epub 2011 Apr 7.

18.

Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Cheung MC, Wolfbauer G, Albers JJ.

Biochim Biophys Acta. 2011 May;1811(5):343-7. doi: 10.1016/j.bbalip.2011.02.001. Epub 2011 Feb 16.

19.

Evaluation of a new homogenous method for detection of small dense LDL cholesterol: comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation.

Albers JJ, Kennedy H, Marcovina SM.

Clin Chim Acta. 2011 Mar 18;412(7-8):556-61. doi: 10.1016/j.cca.2010.12.003. Epub 2010 Dec 11.

PMID:
21156166
20.

Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation.

Cheung MC, Vaisar T, Han X, Heinecke JW, Albers JJ.

Biochemistry. 2010 Aug 31;49(34):7314-22. doi: 10.1021/bi100359f.

21.

Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Cheung MC, Albers JJ, Kennedy H, Deguchi H, Elias DJ, Averell PM, Griffin JH, Marcovina SM.

Clin Chim Acta. 2010 Sep 6;411(17-18):1279-83. doi: 10.1016/j.cca.2010.05.012. Epub 2010 May 19.

22.

Genetic and nongenetic sources of variation in phospholipid transfer protein activity.

Jarvik GP, Rajagopalan R, Rosenthal EA, Wolfbauer G, McKinstry L, Vaze A, Brunzell J, Motulsky AG, Nickerson DA, Heagerty PJ, Wijsman EM, Albers JJ.

J Lipid Res. 2010 May;51(5):983-90. doi: 10.1194/jlr.M000125. Epub 2009 Nov 2.

24.

Phospholipid transfer protein reduces phosphorylation of tau in human neuronal cells.

Dong W, Albers JJ, Vuletic S.

J Neurosci Res. 2009 Nov 1;87(14):3176-85. doi: 10.1002/jnr.22137.

25.

Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells.

Dong W, Vuletic S, Albers JJ.

J Lipid Res. 2009 Oct;50(10):2095-102. doi: 10.1194/jlr.M900236-JLR200. Epub 2009 May 21.

26.

PLTP is present in the nucleus, and its nuclear export is CRM1-dependent.

Vuletic S, Dong W, Wolfbauer G, Day JR, Albers JJ.

Biochim Biophys Acta. 2009 Mar;1793(3):584-91. doi: 10.1016/j.bbamcr.2009.01.010. Epub 2009 Jan 24.

27.

Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Cheung MC, Wolfbauer G, Deguchi H, Fernández JA, Griffin JH, Albers JJ.

Biochim Biophys Acta. 2009 Mar;1791(3):206-11. doi: 10.1016/j.bbalip.2008.12.010. Epub 2008 Dec 30.

28.

Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.

Vuletic S, Li G, Peskind ER, Kennedy H, Marcovina SM, Leverenz JB, Petrie EC, Lee VM, Galasko D, Schellenberg GD, Albers JJ.

J Alzheimers Dis. 2008 Nov;15(3):409-17.

29.

SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction.

Vuletic S, Taylor BA, Tofler GH, Chait A, Marcovina SM, Schenck K, Albers JJ.

Oral Dis. 2008 Sep;14(6):514-9. doi: 10.1111/j.1601-0825.2007.01411.x.

PMID:
18826383
30.

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.

Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, Yu CE.

J Alzheimers Dis. 2008 Apr;13(3):255-66.

31.

An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux.

Oram JF, Wolfbauer G, Tang C, Davidson WS, Albers JJ.

J Biol Chem. 2008 Apr 25;283(17):11541-9. doi: 10.1074/jbc.M800117200. Epub 2008 Feb 19.

32.

Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes.

Albers JJ, Marcovina SM, Imperatore G, Snively BM, Stafford J, Fujimoto WY, Mayer-Davis EJ, Petitti DB, Pihoker C, Dolan L, Dabelea DM.

J Clin Endocrinol Metab. 2008 Mar;93(3):735-42. Epub 2007 Dec 18.

33.

Evidence mounts for a role of the kidney in lipoprotein(a) catabolism.

Albers JJ, Koschinsky ML, Marcovina SM.

Kidney Int. 2007 May;71(10):961-2.

34.

Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.

Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER.

J Alzheimers Dis. 2006 Dec;10(4):399-406.

PMID:
17183151
35.

Statins of different brain penetrability differentially affect CSF PLTP activity.

Vuletic S, Riekse RG, Marcovina SM, Peskind ER, Hazzard WR, Albers JJ.

Dement Geriatr Cogn Disord. 2006;22(5-6):392-8. Epub 2006 Sep 7.

PMID:
16960448
36.
37.

Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease.

Cheung MC, Brown BG, Marino Larsen EK, Frutkin AD, O'Brien KD, Albers JJ.

Biochim Biophys Acta. 2006 Jan;1762(1):131-7. Epub 2005 Sep 21.

38.

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.

Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ.

J Neurosci Res. 2005 May 1;80(3):406-13.

PMID:
15795933
39.

Low-density lipoprotein inhibits secretion of phospholipid transfer protein in human trophoblastic BeWo cells.

Tu AY, Cheung MC, Zhu X, Knopp RH, Albers JJ.

Exp Biol Med (Maywood). 2004 Nov;229(10):1046-52.

PMID:
15522841
40.

Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism.

Albers JJ, Cheung MC.

Curr Opin Lipidol. 2004 Jun;15(3):255-60. Review.

PMID:
15166780
41.

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).

Zhao XQ, Morse JS, Dowdy AA, Heise N, DeAngelis D, Frohlich J, Chait A, Albers JJ, Brown BG.

Am J Cardiol. 2004 Feb 1;93(3):307-12.

PMID:
14759379
42.

Quantitative trait locus mapping of genes that regulate phospholipid transfer activity in SM/J and NZB/BlNJ inbred mice.

Korstanje R, Albers JJ, Wolfbauer G, Li R, Tu AY, Churchill GA, Paigen BJ.

Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):155-60. Epub 2003 Oct 30.

PMID:
14592843
43.
44.

Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells.

Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ.

J Biol Chem. 2003 Dec 26;278(52):52379-85. Epub 2003 Oct 14.

45.

PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity.

Murdoch SJ, Kahn SE, Albers JJ, Brunzell JD, Purnell JQ.

J Lipid Res. 2003 Sep;44(9):1705-12. Epub 2003 Jul 1.

46.

Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.

O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, Albers JJ.

Circulation. 2003 Jul 22;108(3):270-4. Epub 2003 Jun 30.

PMID:
12835223
47.

Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease.

Vuletic S, Jin LW, Marcovina SM, Peskind ER, Moller T, Albers JJ.

J Lipid Res. 2003 Jun;44(6):1113-23. Epub 2003 Apr 1.

48.

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution.

Murdoch SJ, Carr MC, Kennedy H, Brunzell JD, Albers JJ.

J Lipid Res. 2002 Aug;43(8):1256-63.

49.

Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity.

Cheung MC, Knopp RH, Retzlaff B, Kennedy H, Wolfbauer G, Albers JJ.

Biochim Biophys Acta. 2002 May 21;1587(1):53-9.

50.

Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice.

Pitman WA, Korstanje R, Churchill GA, Nicodeme E, Albers JJ, Cheung MC, Staton MA, Sampson SS, Harris S, Paigen B.

Physiol Genomics. 2002;9(2):93-102.

PMID:
12006675

Supplemental Content

Loading ...
Support Center